From March 10, 2023 to April 10, 2023, the company has repurchased 2,210,500 shares, representing 1.73% for INR 3,149.96 million. With this, the company has completed the repurchase of 2,210,500 shares, representing 1.73% for INR 3,149.96 million under the buyback announced on March 10, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,234 INR | +0.84% | +4.87% | +7.22% |
May. 02 | Ajanta Pharma's Consolidated Profit Nearly Doubles in Fiscal Q4 | MT |
May. 02 | Ajanta Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.22% | 3.34B | |
+20.61% | 43.18B | |
+20.67% | 22.59B | |
+14.56% | 14.56B | |
+13.94% | 13.54B | |
+43.35% | 11.5B | |
-8.37% | 6.93B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+10.21% | 5.36B |
- Stock Market
- Equities
- AJANTPHARM Stock
- News Ajanta Pharma Limited
- Tranche Update on Ajanta Pharma Limited's Equity Buyback Plan announced on March 10, 2023.